Surgical Simulation Market is anticipated to grow at a CAGR of 24.1% from 2023-2032, and to reach a revenue of US$ 3.1 Bn | According to Persistence Market Research
January 27, 2023 09:10 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
New York, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The Surgical Simulation Market was estimated at US$ 304.1 Mn in 2021 and is anticipated to grow at a CAGR of 24.1% from 2022-2032, according to a recently...
Cardiovascular And Soft Tissue Repair Patches Global Market Report 2022: Growing Demand for Patches in Cardiac Disease Propels Sector
December 30, 2022 07:13 ET
|
Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "Cardiovascular And Soft Tissue Repair Patches Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's...
Heparin Market Size is projected to reach USD 11.89 Billion by 2030, growing at a CAGR of 6.8%: Straits Research
September 01, 2022 12:20 ET
|
Straits Research
New York, United States, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Heparin is an anticoagulant and glycosaminoglycan naturally produced by all mammals' basophils and mast cells. It prevents blood clots...
Flowable Hemostats Market Size Worth $458.9 million Globally, by 2028 at CAGR of 7.1% - Exclusive Report by The Insight Partners
July 13, 2022 08:30 ET
|
The Insight Partners
New York, July 13, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Flowable Hemostats Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Material,...
Worldwide Fractional Flow Reserve Industry to 2027 - Increasing Number of Cath Labs is Driving Growth
July 07, 2022 05:28 ET
|
Research and Markets
Dublin, July 07, 2022 (GLOBE NEWSWIRE) -- The "Fractional Flow Reserve Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The fractional...
Autotransfusion Devices Market Size Worth $1.33Bn, Globally, by 2028 at 4.2% CAGR - Exclusive Report by The Insight Partners
April 07, 2022 11:21 ET
|
The Insight Partners
New York, April 07, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Autotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type...
The Worldwide Motorized Thrombectomy Industry is Expected to Reach $1 Billion in 2026
January 31, 2022 05:38 ET
|
Research and Markets
Dublin, Jan. 31, 2022 (GLOBE NEWSWIRE) -- The "Motorized Thrombectomy Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global motorized...
Angion Provides Corporate Update and Reports Second Quarter 2021 Financial Results
August 12, 2021 16:05 ET
|
Angion Biomedica Corp.
-- Topline data in ANG-3777 Phase 3 study now expected to be announced in early Q4 rather than at year end -- Phase 1 data demonstrated ANG-3070 was well-tolerated across dose cohorts, achieving drug...
Angion and Vifor Pharma Announce Completion of Enrollment in Phase 2 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury
April 29, 2021 00:05 ET
|
Angion Biomedica Corp.
UNIONDALE, N.Y. and ST. GALLEN, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN) and Vifor Pharma today announced completion of enrollment for Angion’s AKI-002-15...
Renibus Therapeutics Initiates Phase 2 Study of RBT-1 for Prevention of Acute Kidney Injury
March 11, 2021 09:00 ET
|
Rénibus Therapeutics Inc.
- Renibus plans to enroll 126 subjects at up to 20 sites across the United States, Canada, Australia, and New Zealand DALLAS, Texas, March 11, 2021 (GLOBE NEWSWIRE) -- Renibus Therapeutics®...